Unfavorable-risk cytogenetics in acute myeloid leukemia. - Wikidata - wikimedia - TriplyDB

Unfavorable-risk cytogenetics in acute myeloid leukemia.

Unfavorable-risk cytogenetics in acute myeloid leukemia.

http://www.wikidata.org/entity/Q37865545

about

The epigenetic landscape of acute myeloid leukemia Epigenetic Guardian: A Review of the DNA Methyltransferase DNMT3A in Acute Myeloid Leukaemia and Clonal Haematopoiesis.Acid ceramidase is upregulated in AML and represents a novel therapeutic target.Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients.CTNNA1 hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcome Aldehyde dehydrogenases in acute myeloid leukemia.CHFR hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcome.Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia.

P2860

Q21284742-23251715-ED9E-4878-9C2F-AC1A18CD487E Q30235316-7671CBAD-6959-485D-AA10-3C6ABEFA5B64 Q30275460-10EB1C5C-573B-434D-A939-139D0B69134F Q36919619-055272E7-8C65-4261-866E-44878D3D65A6 Q37327786-9584505E-435B-43C1-8870-75A0F69049F5 Q38196948-365A0A8E-3C81-4026-8654-CA13C6A1FEDA Q52904336-53E14F76-4920-47B5-B6E4-9B2A8C147C12 Q54539380-66748C9D-F531-436C-B217-D36EB6C5069C

P2860

Unfavorable-risk cytogenetics in acute myeloid leukemia.

http://www.wikidata.org/entity/Q37865545

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Unfavorable-risk cytogenetics in acute myeloid leukemia.

@en

Unfavorable-risk cytogenetics in acute myeloid leukemia.

@nl

type

label

Unfavorable-risk cytogenetics in acute myeloid leukemia.

@en

Unfavorable-risk cytogenetics in acute myeloid leukemia.

@nl

prefLabel

Unfavorable-risk cytogenetics in acute myeloid leukemia.

@en

Unfavorable-risk cytogenetics in acute myeloid leukemia.

@nl

P1433

Q37865545-44EF7AE2-9F92-4485-BE43-6935E9B7A947

P1476

Q37865545-4D1BBEF2-8C2D-44A7-9EA5-EC0C6C4576AB

P2093

Q37865545-4BB50AA7-AA2E-4550-A7F0-2DAA675B3AD9

Q37865545-E28B416C-DAE6-492A-B2A4-FB4577101255

P2860

Q37865545-0AC1A717-1D78-450C-A3AB-DF64833D8D37

Q37865545-0F341117-DCA6-4D51-BBE2-F5856CAFA4B7

Q37865545-11F3C02F-BDF7-4F2A-9278-30E5CAB7E62F

Q37865545-17143F07-A20B-48B5-AEDF-9CC7B520053F

Q37865545-189B6016-BCBB-4106-8A32-FBE22B8A2054

Q37865545-1A206B13-748C-4590-BD2E-394C22FBD6A6

Q37865545-20494BE9-6E7F-4EE0-A612-C69D75D7CF49

Q37865545-25BE4540-C4B0-47A0-A095-F4DCD3F6C7AD

Q37865545-2822B9DA-8A74-49B8-B062-4B383AF3352C

Q37865545-2A3D34EF-011B-4AF6-9F60-ACA3382E23C0

P304

Q37865545-E1CCA06B-BF4A-4833-882A-DB95E0B7267D

P31

Q37865545-4C54127F-5776-4B1D-8A5E-AC81EB2846E8

P356

Q37865545-826A9002-62FF-4BDC-BD21-42A55F43C753

P433

Q37865545-D5963DEF-14E7-4B24-92DD-9BE8B990A176

P478

Q37865545-AAF0D19D-D1E1-4DB8-A953-22B159BDDABE

P577

Q37865545-2EF21B2B-5B72-4C92-B2D9-389130C4617F

P698

Q37865545-83E0251E-B075-439D-8176-BDD1D75667F0

P921

Q37865545-6F1003C1-753D-4B31-97DE-DB239AD4009B

P356

P1433

Expert Review of Hematology

P1476

Unfavorable-risk cytogenetics in acute myeloid leukemia.

@en

P2093

Bruno C Medeiros

http://www.w3.org/2001/XMLSchema#string

Wan-Jen Hong

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Various distinctive cytogenetic abnormalities in patients with acute myeloid leukaemia aged 60 years and older express adverse prognostic value: results from a prospective clinical trial.

Cytogenetics in acute leukemia.

Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.

P304

173-184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/EHM.11.10

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21495927

http://www.w3.org/2001/XMLSchema#string

P921